AQR Arbitrage’s Centessa Pharmaceuticals CNTA Stock Holding History

AQR Arbitrage’s Portfolio CNTA Stock Details CNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-98,028	Closed	-$3.89M	–	641
2026 Q1	$3.89M	Buy	+98,028	New	+$2.51M	0.06%	272

AQR Arbitrage's CNTA Position: Q2 2026 in Review

AQR Arbitrage sold out of Centessa Pharmaceuticals (CNTA) in Q2 2026, closing a stake of 98,028 shares — an estimated $3.89M sold.

AQR Arbitrage first reported a position in CNTA in Q1 2026 and held it in 1 quarter. The position peaked at $3.89M in Q1 2026. 0 funds tracked by Wall St. Rank hold CNTA as of Q2 2026.

AQR Arbitrage reported no remaining Centessa Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
AQR Arbitrage sold 98,028 Centessa Pharmaceuticals shares in Q2 2026, an estimated $3.89M.
AQR Arbitrage first reported a position in Centessa Pharmaceuticals in Q1 2026 and held it in 1 quarter.
AQR Arbitrage's Centessa Pharmaceuticals position peaked at $3.89M in Q1 2026.
0 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q2 2026.

Based on AQR Arbitrage's 13F filing for Q2 2026, filed 14 Aug 2026.